Approximately half of the cases demonstrated complete conversion from BCP-ALL to CD19-negative AML, while the remainder displayed more complex immunophenotypic patterns characterized by the coexistence of residual CD19-positive B lymphoblasts with newly emergent CD19-negative blast populations of either myeloid or unclassifiable lineage. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.